Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

The Ashitaba (Angelica keiskei) Chalcones 4-hydroxyderricin and Xanthoangelol Suppress Melanomagenesis By Targeting BRAF and PI3K.

Zhang T, Wang Q, Fredimoses M, Gao G, Wang K, Chen H, Wang T, Oi N, Zykova TA, Reddy K, Yao K, Ma W, Chang X, Lee MH, Rathore MG, Bode AM, Ashida H, Lippman SM, Dong Z.

Cancer Prev Res (Phila). 2018 Oct;11(10):607-620. doi: 10.1158/1940-6207.CAPR-18-0092. Epub 2018 Jul 6.

PMID:
29980517
2.

Human Leukemic Cells performing Oxidative Phosphorylation (OXPHOS) Generate an Antioxidant Response Independently of Reactive Oxygen species (ROS) Production.

Khan AUH, Rathore MG, Allende-Vega N, Vo DN, Belkhala S, Orecchioni S, Talarico G, Bertolini F, Cartron G, Lecellier CH, Villalba M.

EBioMedicine. 2015 Nov 26;3:43-53. doi: 10.1016/j.ebiom.2015.11.045. eCollection 2016 Jan.

3.

Extracellular-signal-regulated kinase 5 modulates the antioxidant response by transcriptionally controlling Sirtuin 1 expression in leukemic cells.

Lopez-Royuela N, Rathore MG, Allende-Vega N, Annicotte JS, Fajas L, Ramachandran B, Gulick T, Villalba M.

Int J Biochem Cell Biol. 2014 Aug;53:253-61. doi: 10.1016/j.biocel.2014.05.026. Epub 2014 May 28.

PMID:
24880091
4.

All-trans retinoic acid (ATRA) induces miR-23a expression, decreases CTSC expression and granzyme B activity leading to impaired NK cell cytotoxicity.

Sanchez-Martínez D, Krzywinska E, Rathore MG, Saumet A, Cornillon A, Lopez-Royuela N, Martínez-Lostao L, Ramirez-Labrada A, Lu ZY, Rossi JF, Fernández-Orth D, Escorza S, Anel A, Lecellier CH, Pardo J, Villalba M.

Int J Biochem Cell Biol. 2014 Apr;49:42-52. doi: 10.1016/j.biocel.2014.01.003. Epub 2014 Jan 15.

PMID:
24440757
5.

IFNα signaling through PKC-θ is essential for antitumor NK cell function.

Comet NR, Aguiló JI, Rathoré MG, Catalán E, Garaude J, Uzé G, Naval J, Pardo J, Villalba M, Anel A.

Oncoimmunology. 2014 Nov 14;3(8):e948705. eCollection 2014.

6.

Chemical metabolic inhibitors for the treatment of blood-borne cancers.

Villalba M, Lopez-Royuela N, Krzywinska E, Rathore MG, Hipskind RA, Haouas H, Allende-Vega N.

Anticancer Agents Med Chem. 2014 Feb;14(2):223-32. Review.

7.

Protein Kinase C-θ (PKC-θ) in Natural Killer Cell Function and Anti-Tumor Immunity.

Anel A, Aguiló JI, Catalán E, Garaude J, Rathore MG, Pardo J, Villalba M.

Front Immunol. 2012 Jul 5;3:187. doi: 10.3389/fimmu.2012.00187. eCollection 2012.

8.

The NF-κB member p65 controls glutamine metabolism through miR-23a.

Rathore MG, Saumet A, Rossi JF, de Bettignies C, Tempé D, Lecellier CH, Villalba M.

Int J Biochem Cell Biol. 2012 Sep;44(9):1448-56. doi: 10.1016/j.biocel.2012.05.011. Epub 2012 May 24.

PMID:
22634383
9.

From tumor cell metabolism to tumor immune escape.

Villalba M, Rathore MG, Lopez-Royuela N, Krzywinska E, Garaude J, Allende-Vega N.

Int J Biochem Cell Biol. 2013 Jan;45(1):106-13. doi: 10.1016/j.biocel.2012.04.024. Epub 2012 May 5. Review.

10.

Oxidative phosphorylation induces de novo expression of the MHC class I in tumor cells through the ERK5 pathway.

Charni S, de Bettignies G, Rathore MG, Aguiló JI, van den Elsen PJ, Haouzi D, Hipskind RA, Enriquez JA, Sanchez-Beato M, Pardo J, Anel A, Villalba M.

J Immunol. 2010 Sep 15;185(6):3498-503. doi: 10.4049/jimmunol.1001250. Epub 2010 Aug 20.

Supplemental Content

Loading ...
Support Center